Search

everythinglearnresearchcommunity

for

Search:↓

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

The combination of encorafenib and binimetinib caused few skin issues.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

A new wound dressing with p-Coumaric acid helps heal diabetic wounds faster by reducing inflammation and promoting skin repair.

Asteraceae plants may help treat diabetes, but more research is needed.

MK-5108 is safe and shows potential against tumors, especially alone.

Deoxyshikonin helps wounds heal faster in diabetic mice.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Jujube fruit extract may reduce kidney damage from ibuprofen in rats.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

The injectable hydrogel effectively speeds up chronic wound healing.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.